APA
Redfield M. M., Chen H. H., Borlaug B. A., Semigran M. J., Lee K. L., Lewis G., LeWinter M. M., Rouleau J. L., Bull D. A., Mann D. L., Deswal A., Stevenson L. W., Givertz M. M., Ofili E. O., O'Connor C. M., Felker G. M., Goldsmith S. R., Bart B. A., McNulty S. E., Ibarra J. C., Lin G., Oh J. K., Patel M. R., Kim R. J., Tracy R. P., Velazquez E. J., Anstrom K. J., Hernandez A. F., Mascette A. M. & Braunwald E. (20130328). Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. : JAMA.
Chicago
Redfield Margaret M, Chen Horng H, Borlaug Barry A, Semigran Marc J, Lee Kerry L, Lewis Gregory, LeWinter Martin M, Rouleau Jean L, Bull David A, Mann Douglas L, Deswal Anita, Stevenson Lynne W, Givertz Michael M, Ofili Elizabeth O, O'Connor Christopher M, Felker G Michael, Goldsmith Steven R, Bart Bradley A, McNulty Steven E, Ibarra Jenny C, Lin Grace, Oh Jae K, Patel Manesh R, Kim Raymond J, Tracy Russell P, Velazquez Eric J, Anstrom Kevin J, Hernandez Adrian F, Mascette Alice M and Braunwald Eugene. 20130328. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. : JAMA.
Harvard
Redfield M. M., Chen H. H., Borlaug B. A., Semigran M. J., Lee K. L., Lewis G., LeWinter M. M., Rouleau J. L., Bull D. A., Mann D. L., Deswal A., Stevenson L. W., Givertz M. M., Ofili E. O., O'Connor C. M., Felker G. M., Goldsmith S. R., Bart B. A., McNulty S. E., Ibarra J. C., Lin G., Oh J. K., Patel M. R., Kim R. J., Tracy R. P., Velazquez E. J., Anstrom K. J., Hernandez A. F., Mascette A. M. and Braunwald E. (20130328). Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. : JAMA.
MLA
Redfield Margaret M, Chen Horng H, Borlaug Barry A, Semigran Marc J, Lee Kerry L, Lewis Gregory, LeWinter Martin M, Rouleau Jean L, Bull David A, Mann Douglas L, Deswal Anita, Stevenson Lynne W, Givertz Michael M, Ofili Elizabeth O, O'Connor Christopher M, Felker G Michael, Goldsmith Steven R, Bart Bradley A, McNulty Steven E, Ibarra Jenny C, Lin Grace, Oh Jae K, Patel Manesh R, Kim Raymond J, Tracy Russell P, Velazquez Eric J, Anstrom Kevin J, Hernandez Adrian F, Mascette Alice M and Braunwald Eugene. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. : JAMA. 20130328.